Peijia Medical Limited (HKG:9996)
Hong Kong · Delayed Price · Currency is HKD 4.975
-0.085 (-1.68%)
Aug 21, 2026, 4:08 PM HKT
Peijia Medical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Peijia Medical stock has a consensus rating of "Strong Buy" and an average price target of $9.94. The average 1-year stock price forecast is 99.80% higher than the current stock price, while the lowest is $8.64 (+73.67%) and the highest is $10.94 (+119.90%).
Price Target: $9.94 (+99.80%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Mar 31, 2026.
Analyst Ratings
The average analyst rating for Peijia Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.00 | Buy | Maintains | $10.00 | +101.01% | Mar 31, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $10.66 | Buy | Maintains | $10.66 | +114.27% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
915.23M
from 712.87M
Increased by 28.39%
Revenue Next Year
1.17B
from 915.23M
Increased by 27.92%
EPS This Year
n/a
from -0.31
EPS Next Year
0.12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.